A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)
NCT06270836
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
255
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Retinopathy
Interventions
DRUG:
Tarcocimab
OTHER:
Sham injection
Sponsor
Kodiak Sciences Inc